Cargando…

Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan

Familial hypercholesterolemia (FH) is a disease characterized by a triad: elevated low-density lipoprotein (LDL) cholesterol, tendon xanthomas, and premature coronary heart disease. Thus, it can be considered as a model disease for hypercholesterolemia and atherosclerotic cardiovascular disease (ASC...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mabuchi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383536/ https://www.ncbi.nlm.nih.gov/pubmed/28179607 http://dx.doi.org/10.5551/jat.RV16008

Ejemplares similares

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021)

The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry
por: Alallaf, Faisal, et al.
Publicado: (2017)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
por: Fairoozy, R. H., et al.
Publicado: (2017)

Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
por: Reddy, Lakshmi Lavanya, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
por: Walzer, S, et al.
Publicado: (2013)

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FH(Marburg) (FH p.W556R)
por: Schaefer, Juergen R., et al.
Publicado: (2012)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemia
por: Fath, Felix, et al.
Publicado: (2021)

The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
por: Al-Rasadi, Khalid, et al.
Publicado: (2020)

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry
por: Alhabib, Khalid F., et al.
Publicado: (2021)

Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems
por: Chen, Peipei, et al.
Publicado: (2019)

GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
por: Kim, Hyoeun, et al.
Publicado: (2020)

Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia
por: Béland-Bonenfant, Sarah, et al.
Publicado: (2020)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
por: Teramoto, Tamio, et al.
Publicado: (2020)

A tale of eleventh-century Japan : Hamamatsu Chūnagon monogatari
por: Sugawara no Takasue no Musume, 1008-
Publicado: (1983)

Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting
por: Mahzari, Moeber, et al.
Publicado: (2021)

The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study
por: Meshkov, Alexey N., et al.
Publicado: (2021)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Publicado: (2023)

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
por: Boutari, Chrysoula, et al.
Publicado: (2022)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
por: Bangash, Hana, et al.
Publicado: (2022)

Association between Familial Hypercholesterolemia and Serum Levels of Cholesterol Synthesis and Absorption Markers: The CACHE Study FH Analysis
por: Matsuki, Kota, et al.
Publicado: (2023)

The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project
por: Ceska, Richard, et al.
Publicado: (2019)

A half century of infrared astronomy — A personal recollection of the footprints in Japan
por: OKUDA, Haruyuki
Publicado: (2019)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
por: Walters, Nicole L., et al.
Publicado: (2023)

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2018)

Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates
por: Rimbert, Antoine, et al.
Publicado: (2022)

Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
por: Mlinaric, Matej, et al.
Publicado: (2020)

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
por: Rizos, Christos V., et al.
Publicado: (2020)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study-
por: Nohara, Atsushi
Publicado: (2022)

A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial
por: Broekhuizen, Karen, et al.
Publicado: (2010)

Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan
por: Matsunaga, Keiji, et al.
Publicado: (2022)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
por: Kastelein, John J. P., et al.
Publicado: (2014)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

FH through the retrospectoscope
por: Thompson, Gilbert R.
Publicado: (2021)

A half century of γ-aminobutyric acid
por: Smart, Trevor G, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_idiomasir7adfsa52tolk4vr8l